Please login to the form below

Not currently logged in
Email:
Password:

Amgen promotes Michael Severino to chief medical officer

He will also take over senior VP global development role from Sean Harper, who is promoted to executive VP, R&D

Michael Severino has been promoted to the dual role of senior VP, global development and corporate chief medical officer at Amgen.

The former VP of global development, Severino will take over from Sean Harper who has been appointed executive VP, R&D at the US biotech.

Harper's appointment was announced in December, 2011, at the same time as CEO Kevin Sharer declared his intention to step down this May.

Severino has spent eight years at Amgen, where he also served as senior director of inflammation early development and head of the company's proof-of-concept group within medical sciences.

His previous experience includes several years at Merck Research Laboratories working across a wide range of therapeutic areas including vaccines, oncology, diabetes and neurosciences.

"Since joining Amgen in 2004, Mike has demonstrated leadership across Amgen's global development organisation and has made significant contributions to the overall advancement of Amgen's pipeline," said Harper.

"Mike brings broad experience and immense expertise to his new role and I am confident that under his leadership, Amgen's global development team will continue to deliver important new medicines for patients with serious illnesses."

Harper joined Amgen in 2002 as vice president of development, and during his time at the company established its medical sciences capability to focus on translational medicine research.

Like Severino, he also has previous experience at Merck Research Laboratories. He is also a member of the PhRMA Regulatory Affairs Coordinating Committee.

16th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics